BioHealth News
United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the achievement of two milestones for…
Read More
Luminoah Wins 8th Annual Crab Trap Competition at BioHealth Capital Region Forum
Luminoah Wins 8th Annual Crab Trap Competition at BioHealth Capital Region Forum Rockville, MD, September 22, 2023 — Luminoah, a MedTech startup located in…
Read More
Maryland Stem Cell Research Fund’s Ruchika Nijhara, PhD, selected as one of The Daily Record’s 2023 Influential Marylanders
Impactful leader of the Maryland Stem Cell Research Fund recognized COLUMBIA, Md. (September 21, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced that…
Read More
FDA awards nearly $7.5 million to pediatric device consortium led by Children’s National Hospital
Federal funding fosters development and commercialization of medical devices designed for children WASHINGTON, D.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- To foster the development…
Read More
Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel Pancreas-Derived Stem Cells
Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran Total venture funding tops…
Read More
Emmes Appoints Peter Ronco as Chief Executive Officer
Ronco’s Global Pharmaceutical Experience Will Support the Next Chapter of Emmes’ Growth and Technology Enablement Rockville, MD, September 20, 2023 – Emmes, a global,…
Read More
BizJournals – D.C. startup Nanochon raising money to fund trials of 3D-printed knee cartilage implant
D.C.’s Nanochon LLC is raising $3.5 million to make it through the final leg of its journey to bring a 3D-printed knee cartilage implant to market.…
Read More
Last Chance to Register for the BioHealth Capital Region Forum 2023!
We're just ONE DAY away from the FREE 9th Annual BioHealth Capital Region Forum, and there's still time to register! Don't miss out on…
Read More
PQE Group Opens Office in Montreal, Quebec, Canada
PQE Group is excited to announce the opening of its newest office in Montreal, Quebec, Canada, marking a significant expansion for the company. The…
Read More
Federal Trade Commission allows Amgen’s $27.8 billion acquisition of Horizon Therapeutics
THOUSAND OAKS, Calif. and DUBLIN, Sept. 1, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves…
Read More
5 Excellent Finalists Chosen for the 8th Annual BHCR Crab Trap
Rockville, Maryland – September 13, 2023 – BioHealth Innovation, Inc. (BHI), a leading regional innovation intermediary, is thrilled to announce the five outstanding finalists…
Read More
Accelerate Investor Conference Returns to Showcase Leading Early-Stage Companies to National Investors
ARLINGTON, Va.--(BUSINESS WIRE)--The Accelerate Investor Conference is back for its third year at George Mason University’s Arlington Campus, November 1-2, 2023. Spurring the region’s innovation…
Read More
Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia
BETHESDA, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company leading the discovery and…
Read More
Altimmune Announces Completion of Dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight
GAITHERSBURG, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the completion of dosing (last subject…
Read More
NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
BELTSVILLE, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat…
Read More